References
- Straatsma BR, Allen RA, Pettit TH. Central serous retinopathy. Trans Pacific Coast Oto-Ophthalmol Soc. 1966;47:107–125.
- Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium: II. Idiopathic central serous choroidopa-thy. Am J Ophthalmol. 1967;63:587–615.
- Klein ML, Van Buskirk EM, Friedman E, Gragoudas E, Chandra S. Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol. 1974;91:247–250.
- Castro-Correia J, Coutinho MF, Rosas V, Maia J. Long-term follow-up of central serous retinopathy in 150 patients. Doc Ophthalmol. 1992;81: 379–386.
- Guyer DR, Yarmuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol. 1994;112:1057–1062.
- Yannuzzi LA, Shakin JL, Fisher YL, Altomonte MA. Peripheral retinal detachments and retinal pigment epithe-lial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology. 1984;91:1554–1572.
- Levine R, Brucker AJ, Robinson F. Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology. 1989;96:854–859.
- Loo RH, Scott IU, Flynn HW Jr, Gass JD, Murray TG, Lewis ML, Rosenfeld PJ, Smiddy WE. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina. 2002;22:19–24.
- Watzke RC, Burton TC, Leaverton PE. Ruby laser photo-coagulation therapy of central serous retinopathy: I. A con-trolled clinical study; II. Factors affecting prognosis. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:0P205-0P211.
- Watzke RC, Burton TC, Woolson RIP. Direct and indirect laser photocoagulation of central serous choroidopathy. Am J Ophthalmol. 1979;88:914–918.
- Leaver P, Williams C. Argon laser photocoagulation treat-ment in central serous retinopathy. Br J Ophthalmol. 1979;63:674–677.
- Robertson DM, Ilstrup D. Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol. 1983;95:457–466.
- Gilbert CM, Owens SL, Smith PD, Fine SL. Long-term follow-up of central serous chorioretinopathy. Br J Oph-thalmol. 1984;68:815–820.
- Robertson DM. Argon laser photocoagulation treatment in central serous chorioretinopathy. Ophthalmology. 1986;93:972–974.
- Slusher MM. Krypton red laser photocoagulation in selected cases of central serous chorioretinopathy. Retina. 1986;6:81–84.
- Ficker L, Vafidis G, While A, Leaver P. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthal-mol. 1988;72:829–834.
- Piccolino FC. Laser treatment of eccentric leaks in central serous chorioretinopathy resulting in disappearance of untreated juxtafoveal leaks. Retina. 1992;12:96–102.
- Burumcek E, Mudun A, Karacorlu S, Arsln MO. Laser photocoagulation for persistent central serous retinopathy. Ophthalmology. 1997;104:616–622.
- Spitznas M. Central serous retinopathy. In: Ryan SJ, ed. Retina. St. Louis: CV Mosby; 1989, vol. 2, pp. 217–227.
- Gass JDM. Symposium: Current status of photocoagulation of macular disease. Photocoagulation treatment of idio-pathic central serous choroidopathy. Trans Am Acad Oph-thalmol Otolaryngol. 1977;83 :0P456-0P467.
- Schatz H, Yarmuzzi LA, Gitter KA. Subretinal neovascu-larization following argon laser photocoagulation treatment for central serous chorioretinopathy: Complication or misdiagnosis? Trans Am Acad Ophthalmol Otolaryngol. 1977;83:0P893-0P906.
- Khosla PK, Rana SS, Tewari HK, Azad RU, Talwar D. Eval-uation of visual function following argon laser photocoag-ulation in central serous retinopathy. Ophthalmic Surg Lasers. 1997;28:693–697.
- Costa RA, Farah ME, Freymuller E, Morales PH, Smith R, Cardillo JA. Choriocapillaris photodynamic therapy using indocyanine green. Am J Ophthalmol. 2001;132:557–565.
- Costa RA, Farah ME, Cardillo JA, Belfort Jr. R. Photody-namic therapy with indocyanine green for occult subfoveal choroidal neovascularization caused by age related macular degeneration. Curr Eye Res. 2001;23:271–275.
- Brancato R, Scialdone A, Pece A, Coscas G, Binaghi M. Eight-year follow-up of central serous chorioretinopathy with and without laser treatment. Graefes Arch Clin Exp Ophthalmol. 1987;225:166–168.
- Gass JDM. Stereoscopic atlas of macular disease. 4th ed. St Louis: Mosby, 1997:52–70.
- Mainster MA, Reichel E. Transpupillary thermotherapy for age-related macular degeneration: Long-pulse photocoagu-lation, apoptosis, and heat shock proteins. Ophthalmic Surg Lasers. 2000;31:359–373.
- Connolly B, Regillo C, Eagle R, Shields C, Shields J, Moran H. The histopathologic effects of transpupillary thermotherapy in human eyes. Invest Ophthalmol Vis Sci. 2001;42(suppl):513. ARVO abstract.
- Liu DL, Andersson-Engels S, Sturesson C, Svanberg K, Hakansson CH, Svanberg S. Tumour vessel damage resulting from laser-induced hyperthermia alone and in combination with photodynamic therapy. Cancer Lett. 1997;111:157–165.
- Decoste S, Farinelli W, Flotte T, Anderson R. Dye-enhanced laser welding for skin closure. Laser Surg Med. 1992;12: 25–32.
- Baumler W, Abels C, Karrer S, WeiB T, Messmann H, Landthaler M, Szeimies R.-M. Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer. 1999;80:360–363.
- Henderson BW, Dougherty TJ. How does photody-namic therapy work? Photochem Photobiol. 1992;55:145–157.
- Roberts W, Hasan T. Role of neovasculature and vascular permeability on the tumor retention of photodynamic agents. Cancer Res. 1992;52:924–930.